Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Buy
658,964
+5,852
+0.9% +$156K 0.5% 48
2025
Q4
$16.3M Buy
653,112
+20,423
+3% +$515K 0.43% 56
2025
Q3
$16.1M Buy
632,689
+8,881
+1% +$219K 0.45% 57
2025
Q2
$15.1M Sell
623,808
-12,880
-2% -$300K 0.46% 55
2025
Q1
$16.1M Buy
636,688
+16,460
+3% +$431K 0.54% 47
2024
Q4
$16.5M Buy
620,228
+58
+0% +$1.57K 0.54% 45
2024
Q3
$17.9M Sell
620,170
-31,432
-5% -$917K 0.59% 49
2024
Q2
$18.2M Sell
651,602
-2,983
-0.5% -$82.1K 0.62% 44
2024
Q1
$18.2M Buy
654,585
+5,155
+0.8% +$143K 0.64% 45
2023
Q4
$18.7M Sell
649,430
-19,518
-3% -$590K 0.72% 40
2023
Q3
$22.2M Buy
668,948
+7,527
+1% +$266K 0.95% 29
2023
Q2
$24.3M Buy
661,421
+1,602
+0.2% +$62.4K 0.99% 25
2023
Q1
$26.9M Buy
659,819
+23,599
+4% +$1.02M 1.14% 19
2022
Q4
$32.6M Sell
636,220
-4,916
-0.8% -$236K 1.47% 14
2022
Q3
$28.1M Buy
641,136
+19,810
+3% +$963K 1.39% 13
2022
Q2
$32.6M Buy
621,326
+9,207
+2% +$469K 1.51% 12
2022
Q1
$31.7M Sell
612,119
-22,372
-4% -$1.16M 1.27% 15
2021
Q4
$37.5M Sell
634,491
-14,203
-2% -$704K 1.42% 15
2021
Q3
$27.9M Buy
648,694
+103,187
+19% +$4.57M 1.12% 21
2021
Q2
$21.4M Buy
545,507
+16,000
+3% +$622K 1% 24
2021
Q1
$19.2M Buy
529,507
+42,177
+9% +$1.5M 0.96% 28
2020
Q4
$17.9M Sell
487,330
-13,995
-3% -$513K 1.03% 24
2020
Q3
$17.5M Buy
501,325
+1,703
+0.3% +$59.7K 1.11% 22
2020
Q2
$15.5M Buy
499,622
+4,288
+0.9% +$146K 1.07% 22
2020
Q1
$15.3M Sell
495,334
-9,228
-2% -$314K 1.25% 17
2019
Q4
$18.8M Buy
504,562
+17,418
+4% +$620K 1.23% 20
2019
Q3
$16.6M Buy
487,144
+43,325
+10% +$1.58M 1.2% 21
2019
Q2
$18.2M Sell
443,819
-24,107
-5% -$957K 1.73% 16
2019
Q1
$18.9M Sell
467,926
-7,012
-1% -$281K 1.71% 14
2018
Q4
$19.7M Sell
474,938
-4,297
-0.9% -$178K 2.03% 11
2018
Q3
$20M Buy
479,235
+2,490
+0.5% +$95.9K 1.86% 11
2018
Q2
$16.4M Buy
476,745
+63,385
+15% +$2.17M 1.63% 16
2018
Q1
$13.9M Buy
413,360
+12,759
+3% +$439K 1.47% 18
2017
Q4
$13.8M Buy
400,601
+4,675
+1% +$159K 1.76% 16
2017
Q3
$13.4M Sell
395,926
-7,113
-2% -$229K 1.6% 18
2017
Q2
$12.8M Sell
403,039
-3,203
-0.8% -$101K 1.77% 17
2017
Q1
$13.2M Sell
406,242
-17,997
-4% -$567K 1.6% 19
2016
Q4
$13.1M Sell
424,239
-2,834
-0.7% -$86.5K 1.65% 20
2016
Q3
$13.7M Sell
427,073
-102,724
-19% -$3.43M 1.79% 15
2016
Q2
$17.7M Buy
529,797
+881
+0.2% +$28.1K 2.27% 7
2016
Q1
$14.9M Buy
528,916
+5,649
+1% +$161K 1.96% 12
2015
Q4
$16M Buy
523,267
+7,509
+1% +$236K 2.14% 11
2015
Q3
$15.4M Buy
515,758
+1,836
+0.4% +$58.9K 2.2% 7
2015
Q2
$16.3M Buy
513,922
+4,127
+0.8% +$135K 2.21% 5
2015
Q1
$16.8M Buy
509,795
+6,196
+1% +$197K 2.28% 5
2014
Q4
$14.9M Sell
503,599
-616
-0.1% -$17.7K 2.04% 10
2014
Q3
$14.1M Buy
504,215
+47,577
+10% +$1.34M 2.07% 10
2014
Q2
$12.9M Buy
456,638
+151,980
+50% +$4.33M 1.85% 15
2014
Q1
$9.28M Buy
304,658
+147,642
+94% +$4.4M 1.41% 29
2013
Q4
$4.56M Buy
157,016
+2,698
+2% +$78.5K 0.7% 53
2013
Q3
$4.21M Sell
154,318
-1,425
-0.9% -$38.8K 0.69% 55
2013
Q2
$4.14M Buy
+155,743
New +$4.3M 0.69% 54

Other funds holding PFE

Busey Bank's PFE Position: Q1 2026 in Review

Busey Bank increased its Pfizer (PFE) stake by 0.9% in Q1 2026, buying an estimated $156K and bringing the position to 658,964 shares worth $18.5M. The position accounts for 0.5% of the portfolio, ranked #48.

Busey Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.5M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Busey Bank held 658,964 shares of Pfizer worth $18.5M as of Q1 2026.
  • Busey Bank bought 5,852 Pfizer shares in Q1 2026, an estimated $156K.
  • Pfizer made up 0.5% of Busey Bank's portfolio in Q1 2026, its #48 holding.
  • Busey Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Busey Bank's Pfizer position peaked at $37.5M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Busey Bank's 13F filing for Q1 2026, filed 28 Apr 2026.